PLUS1
8.66
-0.08 (-0.92%)
-0.08 (-0.92%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Hancock Jaffe Laboratories Inc | HJLI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.08 | -0.92% | 8.66 | 15:14:46 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 8.73 | 8.56 | 8.78 | 8.74 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 8.62 | 8.67 | 0.05 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 621 | 81,000 | $ 8.65 | $ 700,511 | 1,059,811 | 0.2111 - 17.68 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:14:30 | 100 | $ 8.66 | USD |
Hancock Jaffe Laboratories Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 19.35M | 2.23M | 2.14M | $ 31.24k | $ - | -12.25 | -1.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 62.50k | 51.20% |
Hancock Jaffe Laboratories News
| Date | Time | Source | News Article |
|---|---|---|---|
| 12/21/2020 | 16:31 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 12/21/2020 | 08:31 | Edgar (US Regulatory) | Securities Registration Statement (s-1) |
| 12/18/2020 | 17:11 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) |
| 12/16/2020 | 12:06 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) |
| 11/24/2020 | 17:17 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 11/17/2020 | 16:17 | Edgar (US Regulatory) | Quarterly Report (10-q) |
| 11/13/2020 | 16:42 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HJLI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 9.05 | 9.05 | 8.26 | 8.71 | 226,185 | -0.39 | -4.31% |
| 1 Month | 8.05 | 9.74 | 7.94 | 8.72 | 208,502 | 0.61 | 7.58% |
| 3 Months | 0.32 | 17.68 | 0.298699 | 5.16 | 1,222,053 | 8.34 | 2,606.25% |
| 6 Months | 0.39 | 17.68 | 0.2705 | 0.8364465 | 6,394,798 | 8.27 | 2,120.51% |
| 1 Year | 0.59 | 17.68 | 0.2111 | 0.7967827 | 3,552,362 | 8.07 | 1,367.8% |
| 3 Years | 5.00 | 17.68 | 0.2111 | 0.8550804 | 1,439,051 | 3.66 | 73.2% |
| 5 Years | 5.00 | 17.68 | 0.2111 | 0.8550804 | 1,439,051 | 3.66 | 73.2% |
Hancock Jaffe Laboratories Description
| Hancock Jaffe Laboratories Inc is a medical device company. It develops and sells biological tissue solutions to treat patients with coronary, vascular, end-stage renal and peripheral arterial diseases in the United States and Europe. The company develops and manufactures implantable cardiovascular bioprosthetic devices. Its key products include Bioprosthetic Heart Valve, CoreoGraft- Bypass Graft, and the Venous Valve. |
